The Manufacturers Life Insurance Company Has $44.69 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

The Manufacturers Life Insurance Company raised its holdings in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 2.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 165,106 shares of the company’s stock after acquiring an additional 3,441 shares during the period. The Manufacturers Life Insurance Company owned about 0.06% of HCA Healthcare worth $44,691,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of HCA. Stone House Investment Management LLC bought a new position in HCA Healthcare in the third quarter valued at about $25,000. Centerpoint Advisors LLC acquired a new position in shares of HCA Healthcare in the fourth quarter valued at approximately $27,000. Atlantic Edge Private Wealth Management LLC acquired a new position in shares of HCA Healthcare in the fourth quarter valued at approximately $27,000. Bruce G. Allen Investments LLC acquired a new position in shares of HCA Healthcare in the fourth quarter valued at approximately $28,000. Finally, Annis Gardner Whiting Capital Advisors LLC acquired a new position in shares of HCA Healthcare in the third quarter valued at approximately $30,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA opened at $336.65 on Thursday. The stock has a market cap of $88.17 billion, a P/E ratio of 16.78, a P/E/G ratio of 1.54 and a beta of 1.69. The business’s fifty day moving average is $319.08 and its 200 day moving average is $309.52. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $340.00. The company has a quick ratio of 1.02, a current ratio of 1.16 and a debt-to-equity ratio of 29.26.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its earnings results on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The firm had revenue of $17.34 billion during the quarter, compared to analyst estimates of $16.81 billion. During the same period last year, the firm posted $4.93 EPS. The business’s revenue was up 11.2% compared to the same quarter last year. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 20.86 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Friday, June 14th will be paid a $0.66 dividend. The ex-dividend date is Friday, June 14th. This represents a $2.64 annualized dividend and a yield of 0.78%. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Chad J. Wasserman sold 344 shares of HCA Healthcare stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $321.97, for a total value of $110,757.68. Following the transaction, the senior vice president now directly owns 2,452 shares of the company’s stock, valued at approximately $789,470.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, SVP Chad J. Wasserman sold 876 shares of the business’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the transaction, the senior vice president now directly owns 1,576 shares of the company’s stock, valued at $520,474. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Chad J. Wasserman sold 344 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $321.97, for a total value of $110,757.68. Following the transaction, the senior vice president now directly owns 2,452 shares in the company, valued at $789,470.44. The disclosure for this sale can be found here. Insiders have sold 13,617 shares of company stock valued at $4,321,986 in the last ninety days. Company insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on HCA shares. TD Cowen lowered their price objective on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research note on Tuesday, April 30th. Robert W. Baird assumed coverage on shares of HCA Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $396.00 target price for the company. Barclays increased their target price on shares of HCA Healthcare from $356.00 to $367.00 and gave the company an “overweight” rating in a research report on Monday, April 29th. Baird R W raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Finally, Oppenheimer increased their target price on shares of HCA Healthcare from $330.00 to $345.00 and gave the company an “outperform” rating in a research report on Monday, April 29th. Four analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $325.59.

Check Out Our Latest Analysis on HCA

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.